These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9811860)

  • 1. Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing.
    Will K; Warnecke G; Wiesmüller L; Deppert W
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13681-6. PubMed ID: 9811860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding of MAR/SAR DNA-elements by mutant p53.
    Müller BF; Paulsen D; Deppert W
    Oncogene; 1996 May; 12(9):1941-52. PubMed ID: 8649855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity MAR-DNA binding is a common property of murine and human mutant p53.
    Will K; Warnecke G; Albrechtsen N; Boulikas T; Deppert W
    J Cell Biochem; 1998 Jun; 69(3):260-70. PubMed ID: 9581865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An atypical homeodomain in SATB1 promotes specific recognition of the key structural element in a matrix attachment region.
    Dickinson LA; Dickinson CD; Kohwi-Shigematsu T
    J Biol Chem; 1997 Apr; 272(17):11463-70. PubMed ID: 9111059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolin is a matrix attachment region DNA-binding protein that specifically recognizes a region with high base-unpairing potential.
    Dickinson LA; Kohwi-Shigematsu T
    Mol Cell Biol; 1995 Jan; 15(1):456-65. PubMed ID: 7799955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between scaffold/matrix attachment region (S/MAR) binding activity and DNA duplex destabilization energy.
    Bode J; Winkelmann S; Götze S; Spiker S; Tsutsui K; Bi C; A K P; Benham C
    J Mol Biol; 2006 Apr; 358(2):597-613. PubMed ID: 16516920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions.
    Deppert W
    J Cell Biochem; 1996 Aug; 62(2):172-80. PubMed ID: 8844397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
    Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant p53: "gain of function" through perturbation of nuclear structure and function?
    Deppert W; Göhler T; Koga H; Kim E
    J Cell Biochem Suppl; 2000; Suppl 35():115-22. PubMed ID: 11389540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel matrix attachment region DNA binding motif identified using a random phage peptide library.
    Wang B; Dickinson LA; Koivunen E; Ruoslahti E; Kohwi-Shigematsu T
    J Biol Chem; 1995 Oct; 270(40):23239-42. PubMed ID: 7559473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53 proteins bind DNA in a DNA structure-selective mode.
    Göhler T; Jäger S; Warnecke G; Yasuda H; Kim E; Deppert W
    Nucleic Acids Res; 2005; 33(3):1087-100. PubMed ID: 15722483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of Amphipathic Cell Penetrating Peptide p28 to Wild Type and Mutated p53 as studied by Raman, Atomic Force and Surface Plasmon Resonance spectroscopies.
    Signorelli S; Santini S; Yamada T; Bizzarri AR; Beattie CW; Cannistraro S
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):910-921. PubMed ID: 28126403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP-1 expression in the mouse is controlled by an autoregulatory loop: PARP-1 binding to an upstream S/MAR element and to a novel recognition motif in its promoter suppresses transcription.
    Vidaković M; Gluch A; Qiao J; Oumard A; Frisch M; Poznanović G; Bode J
    J Mol Biol; 2009 May; 388(4):730-50. PubMed ID: 19303024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions.
    Benham C; Kohwi-Shigematsu T; Bode J
    J Mol Biol; 1997 Nov; 274(2):181-96. PubMed ID: 9398526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsically disordered domain of tumor suppressor p53 facilitates target search by ultrafast transfer between different DNA strands.
    Itoh Y; Murata A; Takahashi S; Kamagata K
    Nucleic Acids Res; 2018 Aug; 46(14):7261-7269. PubMed ID: 29986056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
    Thomas S; Reisman D
    Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro analysis of the dominant negative effect of p53 mutants.
    Chène P
    J Mol Biol; 1998 Aug; 281(2):205-9. PubMed ID: 9698540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters.
    Dell'Orso S; Fontemaggi G; Stambolsky P; Goeman F; Voellenkle C; Levrero M; Strano S; Rotter V; Oren M; Blandino G
    OMICS; 2011 May; 15(5):305-12. PubMed ID: 21332394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.